Desmopressin Acetate Nasal Spray Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Apotex Corp. is voluntarily recalling Desmopressin Nasal Spray due to defects in bottle caps, affecting a specific lot distributed in the United States.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Apotex Corp. is recalling Desmopressin Nasal Spray because of a defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Which Products Are Affected
The affected product is Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), with Lot number VM4231 and expiration date 06/2027. The NDC number is 60505-0815-0. The quantity affected is not specified, and distribution was within the United States.
What You Should Do
Consumers with the affected product should contact Apotex Corp. for instructions, as the recall was initiated via e-mail. The recalling firm is located at 2400 N Commerce Pkwy Ste 400, Weston, FL 33326-3253.
Why This Matters
This recall highlights potential risks associated with defective packaging for prescription drugs, which could impact medication efficacy and patient safety in the United States.
Source
Attribution: FDA (U.S. Food and Drug Administration)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (962 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.